Abstract
Side effects such as cutaneous vasculitis, which occur during prolonged levamisole treatment, may discourage the utilization of the drug in relapsing nephrotic syndrome. We describe a child who developed disseminated vasculitis during prolonged treatment with levamisole. The acute phase was characterized by hepatosplenomegaly, hemolytic anemia, IgM anticardiolipin and p-antineutrophil cytoplasmic antibodies. One month after withdrawal of therapy all symptoms had disappeared and tests normalized. This case report, together with other reports on cutaneous vasculitis, suggest caution and close monitoring during prolonged levamisole therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 24 June 1998 / Revised: 17 November 1998 / Accepted: 20 November 1998
Rights and permissions
About this article
Cite this article
Barbano, G., Ginevri, F., Ghiggeri, G. et al. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13, 602–603 (1999). https://doi.org/10.1007/s004670050753
Issue Date:
DOI: https://doi.org/10.1007/s004670050753